CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 21 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,767,000 | -0.1% | 2,525,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,768,000 | +65.4% | 2,525,000 | +77.2% | 0.00% | – |
| Q1 2022 | $1,069,000 | +7.9% | 1,425,000 | 0.0% | 0.00% | – |
| Q4 2021 | $991,000 | -3.6% | 1,425,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,028,000 | -1.6% | 1,425,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,045,000 | -3.0% | 1,425,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,077,000 | +32.1% | 1,425,000 | +21.3% | 0.00% | – |
| Q4 2020 | $815,000 | -0.9% | 1,175,000 | 0.0% | 0.00% | – |
| Q3 2020 | $822,000 | +101.0% | 1,175,000 | +74.1% | 0.00% | – |
| Q2 2020 | $409,000 | +2.5% | 675,000 | 0.0% | 0.00% | – |
| Q1 2020 | $399,000 | -9.1% | 675,000 | -3.6% | 0.00% | – |
| Q4 2019 | $439,000 | +49.8% | 700,000 | 0.0% | 0.00% | – |
| Q3 2019 | $293,000 | -32.6% | 700,000 | 0.0% | 0.00% | – |
| Q2 2019 | $435,000 | -20.3% | 700,000 | 0.0% | 0.00% | – |
| Q1 2019 | $546,000 | -27.4% | 700,000 | -34.9% | 0.00% | – |
| Q4 2018 | $752,000 | +8.0% | 1,075,000 | +19.4% | 0.00% | – |
| Q3 2018 | $696,000 | +59.3% | 900,000 | +89.5% | 0.00% | – |
| Q2 2018 | $437,000 | – | 475,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|